United Therapeutics Corporation (UTHR) is listed on NASDAQ in Pharmaceutical Stocks. It is $515.52, -2.35%, with a $22.1B market cap. RSI is 46.7, neutral. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 46.7 Neutral
Market Cap $22.1B
Volume 223.4K
Fundamentals — 10-Q Q2 2026
Revenue $1.6B
Net Income $607.9M
EPS $13.07
Gross Margin 85.1%
Operating Margin 42.0%
Net Margin 38.8%
P/E Ratio 39.4x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Rothblatt Martine A | Chairperson & CEO | Sell | 9,500 | $522.57 | $5.0M | 2026 Aug 27 |
| Rothblatt Martine A | Chairperson & CEO | Sell | 9,500 | $517.28 | $4.9M | 2026 Aug 26 |
| Rothblatt Martine A | Chairperson & CEO | Sell | 9,500 | $517.71 | $4.9M | 2026 Aug 25 |
| Rothblatt Martine A | Chairperson & CEO | Sell | 9,500 | $511.97 | $4.9M | 2026 Aug 24 |
| Rothblatt Martine A | Chairperson & CEO | Sell | 9,500 | $518.39 | $4.9M | 2026 Aug 21 |
| Rothblatt Martine A | Chairperson & CEO | Sell | 9,500 | $521.02 | $4.9M | 2026 Aug 20 |
| Mahon Paul A | EVP & GENERAL COUNSEL | Sell | 8,300 | $523.14 | $4.3M | 2026 Aug 20 |
| Rothblatt Martine A | Chairperson & CEO | Sell | 9,500 | $526.96 | $5.0M | 2026 Aug 19 |
| Rothblatt Martine A | Chairperson & CEO | Sell | 9,500 | $515.60 | $4.9M | 2026 Aug 18 |
| Rothblatt Martine A | Chairperson & CEO | Sell | 9,500 | $506.59 | $4.8M | 2026 Aug 17 |
| Rothblatt Martine A | Chairperson & CEO | Sell | 9,500 | $498.91 | $4.7M | 2026 Aug 14 |
| Rothblatt Martine A | Chairperson & CEO | Sell | 9,500 | $504.24 | $4.8M | 2026 Aug 13 |
| Rothblatt Martine A | Chairperson & CEO | Sell | 9,500 | $515.03 | $4.9M | 2026 Aug 12 |
| Rothblatt Martine A | Chairperson & CEO | Sell | 9,500 | $522.87 | $5.0M | 2026 Aug 11 |
| Rothblatt Martine A | Chairperson & CEO | Sell | 9,500 | $530.11 | $5.0M | 2026 Aug 10 |
| Rothblatt Martine A | Chairperson & CEO | Sell | 9,500 | $531.38 | $5.0M | 2026 Aug 7 |
| Rothblatt Martine A | Chairperson & CEO | Sell | 9,500 | $525.36 | $5.0M | 2026 Aug 6 |
| Mahon Paul A | EVP & GENERAL COUNSEL | Sell | 8,300 | $517.05 | $4.3M | 2026 Aug 6 |
| Rothblatt Martine A | Chairperson & CEO | Sell | 9,500 | $518.74 | $4.9M | 2026 Aug 5 |
| Rothblatt Martine A | Chairperson & CEO | Sell | 9,500 | $517.09 | $4.9M | 2026 Aug 4 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $153.79 | 49.7 | -- |
| | $236.99 | 45.2 | $31.7B |
| | $36.44 | 58.3 | $42.5B |
| | $77.31 | 53.6 | $31.9B |
| | $34.70 | 44.3 | $25.1B |
Take UTHR further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put UTHR in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when United Therapeutics Corporation next reports.
Set alerts on UTHR
Get notified when United Therapeutics Corporation hits your price targets or technical conditions are met.
Get Started Free